But that all changed in 2023 when she started using Mounjaro, a drug in the new class of GLP-1 (glucagon-like peptide-1) weight-loss medications
By stabilizing neuronal activity within these circuits, the medication reduces the hedonic pull toward sugary, salty, or highly processed foods
If you have questions about starting a GLP-1 drug or making a change to your current regimen, discuss it with your healthcare provider
It is derived from a partial sequence of the Body Protection Compound (BPC) protein, which is naturally isolated from gastric juice in the human digestive tract
Conversely, brain IR, less recognized but equally important, pertains to impaired insulin signaling in neuronal and glial cells [6]
There is no objective measurement of GLP-1 levels or body composition changes